Monthly Dosing of Atacicept in IgAN

NCT07020923 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy (IgAN)
Berger Disease

Interventions

DRUG: Atacicept

Sponsor

Vera Therapeutics, Inc.